Intrum: Intrum AB - Interim results July-September 2024
Intrum delivers steady financial performance in third quarter and makes significant progress towards key financial targets and comprehensive recapitalisation Continued expansion of Servicing margin an ...
iliad SA successfully issues inaugural €500 million green bond
Press release Paris, October 22, 2024 iliad SA successfully issues inaugural €500 million green bond Financial releaseToday, iliad SA successfully placed a €500 million green bond issue. The ...
Concentric AB: Concentric has applied for delisting of its shares from Nasdaq Stockholm
On August 29, 2024, Circle BidCo ApS ("Circle BidCo"), a wholly owned, indirect subsidiary of A.P. Møller Holding A/S, announced a public offer to the shareholders of Concentric AB ("Concentric" or th ...
Magnolia Bostad AB: Magnolia Bostad Interim report Jan-Sep 2024
During Q3, we completed around 400 residential units and counting from the start of the year, we have completed and delivered a total of around 2,500 units. 2024 will be a record year for the company ...
JBT Corporation Reports Strong Third Quarter 2024 Results and Reiterates Full Year 2024 Guidance for Revenue, Adjusted EBITDA, and Adjusted EPS
JBT Corporation (NYSE: JBT), a leading global technology solutions provider to high-value segments of the food & beverage industry, today reported results for the third quarter ...
PennyMac Mortgage Investment Trust Reports Third Quarter 2024 Results
PennyMac Mortgage Investment Trust (NYSE: PMT) today reported net income attributable to common shareholders of $31.0 million, or $0.36 per common share ...
Franklin Financial Services Corporation: Franklin Financial Reports 2024 Q3 and Year-to-Date Results; Declares Dividend
Franklin Financial Services Corporation (the Corporation) (NASDAQ: FRAF), the bank holding company of F&M Trust (the Bank) headquartered in Chambersburg ...
Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications
CAL101 is an anti-S100A4 monoclonal antibody (mAb) and Calluna's lead drug candidate Study demonstrated a favorable safety, pharmacokinetic (PK) and immunogenicity profile CAL101 is ...
Nabors Industries Ltd.: Nabors Announces Third Quarter 2024 Results
Nabors Industries Ltd. ("Nabors" or the "Company") (NYSE: NBR) today reported third quarter 2024 operating revenues of $732 million, compared to operating ...
Founder Group Ltd: Founder Group Limited Announces Pricing of Initial Public Offering
Founder Group Limited ("FGL" or the "Company"), a pure-play, end-to-end engineering, procurement, construction and commissioning (EPCC) solutions ...
Range Resources Corporation: Range Announces Third Quarter 2024 Results
RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its third quarter 2024 financial results. Third Quarter 2024 Highlights - Cash flow from ...
Valmont Reports Third Quarter 2024 Results
Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides vital infrastructure and advances agricultural productivity while driving innovation through technology ...